Gould R A, Mueser K T, Bolton E, Mays V, Goff D
Psychotic Disorders Program, Massachusetts General Hospital/ Harvard Medical School, Boston, MA 02114, USA.
Schizophr Res. 2001 Mar 30;48(2-3):335-42. doi: 10.1016/s0920-9964(00)00145-6.
We conducted a meta-analysis using all available controlled treatment outcome studies of cognitive therapy (CT) for psychotic symptoms in schizophrenia. Effect sizes were calculated for seven studies involving 340 subjects. The mean effect size for reduction of psychotic symptoms was 0.65. The findings suggest that cognitive therapy is an effective treatment for patients with schizophrenia who have persistent psychotic symptoms. Follow-up analyses in four studies indicated that patients receiving CT continued to make gains over time (ES=0.93). Further research is needed to determine the replicability of standardized cognitive interventions, to evaluate the clinical significance of cognitive therapy for schizophrenia, and to determine which patients are most likely to benefit from this intervention.
我们使用了所有现有的关于精神分裂症患者精神病性症状的认知疗法(CT)对照治疗结果研究进行了一项荟萃分析。对涉及340名受试者的7项研究计算了效应量。减少精神病性症状的平均效应量为0.65。研究结果表明,认知疗法对有持续性精神病性症状的精神分裂症患者是一种有效的治疗方法。四项研究的随访分析表明,接受认知疗法的患者随着时间的推移持续有所改善(效应量=0.93)。需要进一步研究以确定标准化认知干预措施的可重复性,评估认知疗法对精神分裂症的临床意义,并确定哪些患者最有可能从这种干预中获益。